Literature DB >> 35176762

Added Value of an Anti-Ebola Serology for the Management of Clinically Suspected Ebola Virus Disease Patients Discharged as Negative in an Epidemic Context.

Antoine Nkuba-Ndaye1,2,3, Daniel Mukadi-Bamuleka2,3, Junior Bulabula-Penge2,3, Guillaume Thaurignac1, François Edidi-Atani2,3, Fabrice Mambu-Mbika2,3, Bernice Danga-Yema3, Meris Matondo-Kuamfumu2,3, Eddy Kinganda-Lusamaki1,2,3, Nella Bisento2, Raphaël Lumembe-Numbi2,3, Gabriel Kabamba-Lungenyi2,3, Divine Kitsa-Mutsumbirwa4, Nelson Kambale-Sivihwa5, François Boillot6, Eric Delaporte1, Placide Mbala-Kingebeni2,3, Ahidjo Ayouba1, Martine Peeters1, Steve Ahuka-Mundeke2,3.   

Abstract

BACKGROUND: Survivors from Ebola virus disease (EVD) may be at the origin of EVD resurgence.
METHODS: Simultaneous reactivity to at least 2 Ebola virus or Zaire ebolavirus (EBOV) antigens was detected in 11 of 488 (2.3%; 95% confidence interval [CI], 1.1-4.0) suspected EVD patients who were discharged as negative after 2 consecutive negative tests during the 10th Ebola outbreak in the Democratic Republic of the Congo.
RESULTS: After extrapolating the total number of individuals discharged as negative during the entire outbreak, we estimated a total of 1314 additional missed Ebola cases.
CONCLUSIONS: These findings emphasize the usefulness of an EBOV serology analysis and the importance of extending epidemic surveillance to clinically suspected cases who were discharged as negative.
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America.

Entities:  

Keywords:  zzm321990 Ebolazzm321990 ; DRC; Ituri; North-Kivu; serology

Mesh:

Year:  2022        PMID: 35176762      PMCID: PMC9400424          DOI: 10.1093/infdis/jiac057

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   7.759


  13 in total

1.  Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study.

Authors:  Mamadou Saliou Kalifa Diallo; Muriel Rabilloud; Ahidjo Ayouba; Abdoulaye Touré; Guillaume Thaurignac; Alpha Kabinet Keita; Christelle Butel; Cécé Kpamou; Thierno Alimou Barry; Mariama Djouldé Sall; Ibrahima Camara; Sandrine Leroy; Philippe Msellati; René Ecochard; Martine Peeters; Mamadou Saliou Sow; Eric Delaporte; Jean-François Etard
Journal:  Lancet Infect Dis       Date:  2019-02-11       Impact factor: 25.071

2.  Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.

Authors:  Ahidjo Ayouba; Abdoulaye Touré; Christelle Butel; Alpha Kabinet Keita; Florian Binetruy; Mamadou S Sow; Vincent Foulongne; Eric Delaporte; Martine Peeters
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

3.  The exacerbation of Ebola outbreaks by conflict in the Democratic Republic of the Congo.

Authors:  Chad R Wells; Abhishek Pandey; Martial L Ndeffo Mbah; Bernard-A Gaüzère; Denis Malvy; Burton H Singer; Alison P Galvani
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-21       Impact factor: 11.205

4.  Human asymptomatic Ebola infection and strong inflammatory response.

Authors:  E M Leroy; S Baize; V E Volchkov; S P Fisher-Hoch; M C Georges-Courbot; J Lansoud-Soukate; M Capron; P Debré; J B McCormick; A J Georges
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

5.  Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus.

Authors:  Judith R Glynn; Hilary Bower; Sembia Johnson; Catherine F Houlihan; Carla Montesano; Janet T Scott; Malcolm G Semple; Mohammed S Bangura; Alie Joshua Kamara; Osman Kamara; Saidu H Mansaray; Daniel Sesay; Cecilia Turay; Steven Dicks; Raoul E Guetiya Wadoum; Vittorio Colizzi; Francesco Checchi; Dhan Samuel; Richard S Tedder
Journal:  Lancet Infect Dis       Date:  2017-02-28       Impact factor: 25.071

6.  Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study.

Authors:  Mamadou Saliou Kalifa Diallo; Ahidjo Ayouba; Alpha Kabinet Keita; Guillaume Thaurignac; Mamadou Saliou Sow; Cécé Kpamou; Thierno Alimou Barry; Philippe Msellati; Jean-François Etard; Martine Peeters; René Ecochard; Eric Delaporte; Abdoulaye Toure
Journal:  Lancet Microbe       Date:  2021-09-03

Review 7.  Ebola Immunity: Gaining a Winning Position in Lightning Chess.

Authors:  Aurélie Ploquin; Yan Zhou; Nancy J Sullivan
Journal:  J Immunol       Date:  2018-08-01       Impact factor: 5.422

8.  Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks.

Authors:  Alpha Kabinet Keita; Fara R Koundouno; Martin Faye; Ariane Düx; Julia Hinzmann; Haby Diallo; Ahidjo Ayouba; Frederic Le Marcis; Barré Soropogui; Kékoura Ifono; Moussa M Diagne; Mamadou S Sow; Joseph A Bore; Sebastien Calvignac-Spencer; Nicole Vidal; Jacob Camara; Mamadou B Keita; Annick Renevey; Amadou Diallo; Abdoul K Soumah; Saa L Millimono; Almudena Mari-Saez; Mamadou Diop; Ahmadou Doré; Fodé Y Soumah; Kaka Kourouma; Nathalie J Vielle; Cheikh Loucoubar; Ibrahima Camara; Karifa Kourouma; Giuditta Annibaldis; Assaïtou Bah; Anke Thielebein; Meike Pahlmann; Steven T Pullan; Miles W Carroll; Joshua Quick; Pierre Formenty; Anais Legand; Karla Pietro; Michael R Wiley; Noel Tordo; Christophe Peyrefitte; John T McCrone; Andrew Rambaut; Youssouf Sidibé; Mamadou D Barry; Madeleine Kourouma; Cé D Saouromou; Mamadou Condé; Moussa Baldé; Moriba Povogui; Sakoba Keita; Mandiou Diakite; Mamadou S Bah; Amadou Sidibe; Dembo Diakite; Fodé B Sako; Fodé A Traore; Georges A Ki-Zerbo; Philippe Lemey; Stephan Günther; Liana E Kafetzopoulou; Amadou A Sall; Eric Delaporte; Sophie Duraffour; Ousmane Faye; Fabian H Leendertz; Martine Peeters; Abdoulaye Toure; N' Faly Magassouba
Journal:  Nature       Date:  2021-09-15       Impact factor: 49.962

9.  Implementation and Operational Research: Programmatic Feasibility of Dried Blood Spots for the Virological Follow-up of Patients on Antiretroviral Treatment in Nord Kivu, Democratic Republic of the Congo.

Authors:  François Boillot; Laetitia Serrano; Jeremie Muwonga; Jean Pierre Kabuayi; Alain Kambale; Fidèle Mutaka; Paula I Fujiwara; Josef Decosas; Martine Peeters; Eric Delaporte
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

10.  Mapping the zoonotic niche of Ebola virus disease in Africa.

Authors:  David M Pigott; Nick Golding; Adrian Mylne; Zhi Huang; Andrew J Henry; Daniel J Weiss; Oliver J Brady; Moritz U G Kraemer; David L Smith; Catherine L Moyes; Samir Bhatt; Peter W Gething; Peter W Horby; Isaac I Bogoch; John S Brownstein; Sumiko R Mekaru; Andrew J Tatem; Kamran Khan; Simon I Hay
Journal:  Elife       Date:  2014-09-08       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.